Particle.news

Download on the App Store

FOGSI and Veha Launch Project MUKTA to Make First-Trimester Thalassemia Screening Routine

FOGSI’s new guidance pushes first‑trimester HPLC testing toward routine antenatal care to curb India’s heavy thalassemia burden.

Thalassemia prevention project launched in city
Image

Overview

  • New Good Clinical Practice Recommendations call for every untested pregnant woman to receive HPLC screening within the first three months.
  • Project MUKTA begins with a planned rollout to 10 cities by end‑2025 before scaling to more than 30 through CME sessions and awareness drives.
  • Organizers will train 70–80 doctors as master trainers to work with medical colleges, diagnostic centres and professional associations.
  • FOGSI leaders urged government bodies to make HPLC a mandatory part of antenatal testing and to expand the effort into public-sector care.
  • India’s thalassemia burden cited by organizers includes roughly 100,000–150,000 children living with the disease, 10,000–15,000 annual births and about 42 million carriers.